Peripheral and central glucose utilizations modulated by mitochondrial DNA 10398A in bipolar disorder

Psychoneuroendocrinology

Volumn 55, Issue , 2015, Pages 72-80

  Li, Cheng Ta ^a,b   Bai, Ya Mei ^a,b   Hsieh, Jen Chuen ^a,b   Lee, Hsin Chen ^b   Yang, Bang Hung ^a   Chen, Mu Hong ^a,b   Lin, Wei Chen ^a,b   Tsai, Chia Fen ^a,b   Tu, Pei Chi ^a,b   Wang, Shyh Jen ^a   Su, Tung Ping ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Bipolar disorder; Gene; Glucose homeostasis; Mitochondria; Polymorphism

Indexed keywords

GLUCOSE; INSULIN; MITOCHONDRIAL DNA; FLUORODEOXYGLUCOSE F 18; GLUCOSE BLOOD LEVEL; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; BIPOLAR DISORDER; BRAIN FUNCTION; CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; FUNCTIONAL ASSESSMENT; GENE FUNCTION; GENE IDENTIFICATION; GENETIC POLYMORPHISM; GLUCOSE BLOOD LEVEL; GLUCOSE UTILIZATION; HUMAN; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; BRAIN; CASE CONTROL STUDY; GENETIC PREDISPOSITION; GENETICS; GLYCOLYSIS; METABOLISM; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; SCINTISCANNING; SIBLING;

ADULT; BIPOLAR DISORDER; BLOOD GLUCOSE; BRAIN; CASE-CONTROL STUDIES; DNA, MITOCHONDRIAL; FEMALE; FLUORODEOXYGLUCOSE F18; GENETIC PREDISPOSITION TO DISEASE; GLYCOLYSIS; HUMANS; INSULIN RESISTANCE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SIBLINGS;

EID: 84925799587     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2015.02.003     Document Type: Article

References (34)

1. Arts B., Jabben N., Krabbendam L., van Os J. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. Psychol. Med. 2008, 38:771-785.
2. Bai Y.M., Chang C.J., Tsai S.Y., Chen Y.C., Hsiao M.C., Li C.T., Tu P., Chang S.W., Shen W.W., Su T.P. Taiwan consensus of pharmacological treatment for bipolar disorder. J. Chin. Med. Assoc. 2013, 76:547-556.
3. Balanza-Martinez V., Rubio C., Selva-Vera G., Martinez-Aran A., Sanchez-Moreno J., Salazar-Fraile J., Vieta E., Tabares-Seisdedos R. Neurocognitive endophenotypes (endophenocognitypes) from studies of relatives of bipolar disorder subjects: a systematic review. Neurosci. Biobehav. Rev. 2008, 32:1426-1438.
4. Baxter L.R., Schwartz J.M., Phelps M.E., Mazziotta J.C., Guze B.H., Selin C.E., Gerner R.H., Sumida R.M. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch. Gen. Psychiatry 1989, 46:243-250.
5. Bingham E.M., Hopkins D., Smith D., Pernet A., Hallett W., Reed L., Marsden P.K., Amiel S.A. The role of insulin in human brain glucose metabolism: an 18fluoro-deoxyglucose positron emission tomography study. Diabetes 2002, 51:3384-3390.
6. Bora E., Yucel M., Pantelis C. Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J. Affect. Disord. 2009, 113:1-20.
7. Buchsbaum M.S., Wu J., DeLisi L.E., Holcomb H., Kessler R., Johnson J., King A.C., Hazlett E., Langston K., Post R.M. Frontal cortex and basal ganglia metabolic rates assessed by positron emission tomography with [18F]2-deoxyglucose in affective illness. J. Affect. Disord. 1986, 10:137-152.
8. Cassidy F., Ahearn E., Carroll B.J. Elevated frequency of diabetes mellitus in hospitalized manic-depressive patients. Am. J. Psychiatry 1999, 156:1417-1420.
9. Cumming T.B., Churilov L., Linden T., Bernhardt J. Montreal Cognitive Assessment and Mini-Mental State Examination are both valid cognitive tools in stroke. Acta Neurol. Scand. 2013, 128:122-129.
10. de Sousa R.T., Machado-Vieira R., Zarate C.A., Manji H.K. Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder. Expert Opin. Ther. Targets 2014, 18:1131-1147.
11. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 1975, 12:189-198.
12. Gershon E.S., Hamovit J., Guroff J.J., Dibble E., Leckman J.F., Sceery W., Targum S.D., Nurnberger J.I., Goldin L.R., Bunney W.E. A family study of schizoaffective, bipolar I, bipolar II, unipolar, and normal control probands. Arch. Gen. Psychiatry 1982, 39:1157-1167.
13. Gispert J.D., Pascau J., Reig S., Martinez-Lazaro R., Molina V., Garcia-Barreno P., Desco M. Influence of the normalization template on the outcome of statistical parametric mapping of PET scans. Neuroimage 2003, 19:601-612.
14. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., Gurtiss G. Wisconsin Card Sorting Test Manual 1993, Psychological Assessment Resources.
15. Hirvonen J., Virtanen K.A., Nummenmaa L., Hannukainen J.C., Honka M.J., Bucci M., Nesterov S.V., Parkkola R., Rinne J., Iozzo P., et al. Effects of insulin on brain glucose metabolism in impaired glucose tolerance. Diabetes 2011, 60:443-447.
16. Kato T., Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord. 2000, 2:180-190.
17. Kato T., Ishiwata M., Mori K., Washizuka S., Tajima O., Akiyama T., Kato N. Mechanisms of altered Ca2+ signalling in transformed lymphoblastoid cells from patients with bipolar disorder. Int. J. Neuropsychopharmacol. 2003, 6:379-389.
18. Kato T. The role of mitochondrial dysfunction in bipolar disorder. Drug News Perspect. 2006, 19:597-602.
19. Kazuno A.A., Munakata K., Nagai T., Shimozono S., Tanaka M., Yoneda M., Kato N., Miyawaki A., Kato T. Identification of mitochondrial DNA polymorphisms that alter mitochondrial matrix pH and intracellular calcium dynamics. PLoS Genet. 2006, 2:e128.
20. Kazuno A.A., Munakata K., Kato N., Kato T. Mitochondrial DNA-dependent effects of valproate on mitochondrial calcium levels in transmitochondrial cybrids. Int. J. Neuropsychopharmacol. 2008, 11:71-78.
21. Kempton M.J., Haldane M., Jogia J., Grasby P.M., Collier D., Frangou S. Dissociable brain structural changes associated with predisposition, resilience, and disease expression in bipolar disorder. J. Neurosci. 2009, 29:10863-10868.
22. Lee D.S., Kang H., Kim H., Park H., Oh J.S., Lee J.S., Lee M.C. Metabolic connectivity by interregional correlation analysis using statistical parametric mapping (SPM) and FDG brain PET; methodological development and patterns of metabolic connectivity in adults. Eur. J. Nucl. Med. Mol. Imaging 2008, 35:1681-1691.
23. Li C.T., Hsieh J.C., Wang S.J., Yang B.H., Bai Y.M., Lin W.C., Lan C.C., Su T.P. Differential relations between fronto-limbic metabolism and executive function in patients with remitted bipolar I and bipolar II disorder. Bipolar Disord. 2012, 14:831-842.
24. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
25. McGuffin P., Rijsdijk F., Andrew M., Sham P., Katz R., Cardno A. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch. Gen. Psychiatry 2003, 60:497-502.
26. Nasreddine Z.S., Phillips N.A., Bedirian V., Charbonneau S., Whitehead V., Collin I., Cummings J.L., Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J. Am. Geriatr. Soc. 2005, 53:695-699.
27. Phielix E., Szendroedi J., Roden M. Mitochondrial function and insulin resistance during aging: a mini-review. Gerontology 2011, 57:387-396.
28. Signorini M., Paulesu E., Friston K., Perani D., Colleluori A., Lucignani G., Grassi F., Bettinardi V., Frackowiak R.S., Fazio F. Rapid assessment of regional cerebral metabolic abnormalities in single subjects with quantitative and nonquantitative [18F]FDG PET: a clinical validation of statistical parametric mapping. Neuroimage 1999, 9:63-80.
29. Singh M.K., Spielman D., Libby A., Adams E., Acquaye T., Howe M., Kelley R., Reiss A., Chang K.D. Neurochemical deficits in the cerebellar vermis in child offspring of parents with bipolar disorder. Bipolar Disord. 2011, 13:189-197.
30. Stork C., Renshaw P.F. Mitochondrial dysfunction in bipolar disorder: evidence from magnetic resonance spectroscopy research. Mol. Psychiatry 2005, 10:900-919.
31. Washizuka S., Ikeda A., Kato N., Kato T. Possible relationship between mitochondrial DNA polymorphisms and lithium response in bipolar disorder. Int. J. Neuropsychopharmacol. 2003, 6:421-424.
32. Willis M.W., Ketter T.A., Kimbrell T.A., George M.S., Herscovitch P., Danielson A.L., Benson B.E., Post R.M. Age, sex and laterality effects on cerebral glucose metabolism in healthy adults. Psychiatry Res. 2002, 114:23-37.
33. Womer F.Y., Wang F., Chepenik L.G., Kalmar J.H., Spencer L., Edmiston E., Pittman B.P., Constable R.T., Papademetris X., Blumberg H.P. Sexually dimorphic features of vermis morphology in bipolar disorder. Bipolar Disord. 2009, 11:753-758.
34. Young S.E., Mainous A.G., Carnemolla M. Hyperinsulinemia and cognitive decline in a middle-aged cohort. Diabetes Care 2006, 29:2688-2693.